Recent Updates
Recently added Catalysts
IONS Positive Sentiment

Ionis to hold third quarter 2023 financial results webcast Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Thursday, November 2nd at 11:30 a.m. Eastern Time to...

Key Takeaway: Ionis Pharmaceuticals, Inc. will host a live webcast on November 2, 2023, at 11:30 a.m. ET to discuss its third quarter financial results. The event will be accessible online, and a replay will be available afterward. Ionis continues to lead in RNA-targeted therapies with a strong pipeline.
Price reaction · baseline $45.98 (2023-10-18 close) · hit after-hours · clean, no other IONS news in the window
day 0 close · peak
+1.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Ionis Pharmaceuticals is hosting a live webcast to discuss financial results.
  • The company has a promising late-stage pipeline in cardiovascular and neurological areas.
  • Ionis has been a leader in RNA-targeted therapy for over 30 years.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+24%
120-day peak, hindsight
Typical move
4.1%
average across 11 past catalysts
Lead asset
ISIS 113715
Phase 2 · Type 2 Diabetes Mellitus

Full Press Release Details

Webcast scheduled for Thursday, November 2 at 11:30 a.m. Eastern Time
CARLSBAD, Calif. , Oct. 19, 2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS ) announced today that it will host a live webcast on Thursday, November 2 nd at 11:30 a.m. Eastern Time to discuss its third quarter 2023 financial results.
The webcast may be accessed at https://ir.ionispharma.com/events-and-presentations/upcoming-events . A replay will be available for a limited time at the same address.
About Ionis Pharmaceuticals, Inc. For more than 30 years, Ionis has been a leader in RNA-targeted therapy, pioneering new markets and changing standards of care. Ionis currently has four marketed medicines and a promising late-stage pipeline highlighted by cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision to become the leader in genetic medicine, utilizing a multi-platform approach to discover, develop and deliver life-transforming therapies.
To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.

Frequently Asked Questions

When is the Ionis Q3 2023 webcast scheduled?

The Ionis Q3 2023 webcast is scheduled for November 2 at 11:30 a.m. ET.

How can I access the Ionis webcast?

The webcast can be accessed at Ionis Pharmaceuticals' investor relations website.

Will there be a replay of the Ionis webcast?

Yes, a replay of the webcast will be available for a limited time.

What is Ionis Pharmaceuticals known for?

Ionis is a leader in RNA-targeted therapy with a strong pipeline and four marketed medicines.

Last updated: Oct 19, 2023